Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for IMDx H1N1 Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has granted emergency use authorization for IntelligentMDx's (IMDx) test for the 2009 H1N1 flu virus, the Cambridge, Mass.-based company said today.

The emergency use authorization does not clear the company's Influenza A H1N1 Real-Time RT-PCR Assay for use beyond the period of the 2009 H1N1 influenza public health emergency, which is currently scheduled to expire on April 26, 2010, unless it is renewed or terminated sooner.

The authorization for the test, which takes around 90 minutes to produce results, includes its use on the Applied Biosystems 7500 system, 7500 Fast Real-Time PCR Systems, and the 7500 Fast Dx Real-Time PCR systems. The authorization covers use of the tests only by CLIA high complexity laboratories to detect and differentiate the 2009 Influenza A H1N1 virus.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.